Baker Avenue Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Baker Avenue Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-502	Closed	-$14K	–	441
2023 Q3	$14K	Buy	502 +387	+337%	+$12.7K	﹤0.01%	709
2023 Q2	$3.92K	Sell	115 -264	-70%	-$8.3K	﹤0.01%	891
2023 Q1	$11.4K	Sell	379 -3,920	-91%	-$121K	﹤0.01%	745
2022 Q4	$121K	Buy	+4,299	New	+$136K	0.01%	380

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Main Management San Francisco, California $1.37B AUM 19.06% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Baker Avenue Asset Management's ARKG Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2023, closing a stake of 502 shares — an estimated $14K sold.

Baker Avenue Asset Management first reported a position in ARKG in Q4 2022 and held it in 4 quarters. The position peaked at $121K in Q4 2022. 298 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

Baker Avenue Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2023 after selling out during the quarter.
Baker Avenue Asset Management sold 502 ARK Genomic Revolution ETF shares in Q4 2023, an estimated $14K.
Baker Avenue Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2022 and held it in 4 quarters.
Baker Avenue Asset Management's ARK Genomic Revolution ETF position peaked at $121K in Q4 2022.
298 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.